MedTrace Logo

EMPOWER - BAME vs COVID

NCT04399733 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-08-26

No results posted yet for this study

Summary

The COVID-19 virus pandemic has massively affected us all. Moreover, there is a disproportionately high number of COVID-19 severe infections and deaths in British Black, Asian and minority ethnic (BAME) patients. This clinical study plans to discover new ways of protecting people from this virus by looking at our DNA and biology.

Conditions

  • COVID-19, SARS-CoV 2 Infection
  • Health Disparities

Sponsors & Collaborators

  • Future Genetics Limited

    lead OTHER

Principal Investigators

  • Dr Mohammed Kamran · Future Genetics Limited

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2023-02-01
Completion
2024-02-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04399733 on ClinicalTrials.gov